Quantum Biopharma Ltd. (QNTM) reporting calendar
Quantum Biopharma Ltd. files periodic reports with the SEC as QNTM on Nasdaq. Atlas tracks 7 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 26 Mar 2026
- Reports on record
- 7
Open QNTM market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 26 Mar 2026 | 85 days | 0001185185-26-001069 |
| 20-F | 31 Dec 2024 | 28 Mar 2025 | 87 days | 0001654954-25-003516 |
| 20-F | 31 Dec 2023 | 2 Apr 2024 | 93 days | 0001654954-24-004067 |
| 20-F | 31 Dec 2022 | 31 Mar 2023 | 90 days | 0001062993-23-008232 |
| 20-F | 31 Dec 2021 | 31 Mar 2022 | 90 days | 0001062993-22-009034 |
| 40-F | 31 Dec 2020 | 17 Mar 2021 | 76 days | 0001062993-21-002769 |
| 40-F | 31 Dec 2019 | 4 Mar 2020 | 64 days | 0001062993-20-001241 |
Source: SEC EDGAR company submissions for CIK 0001771885. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.